相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Parecoxib and its metabolite valdecoxib directly interact with cannabinoid binding sites in CB1-expressing HEK 293 cells and rat brain tissue
Helmut Schroeder et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Electroencephalographic responses of tramadol, parecoxib and morphine to acute noxious electrical stimulation in anaesthetised dogs
Kavitha Kongara et al.
RESEARCH IN VETERINARY SCIENCE (2010)
Separation and determination of rofecoxib and its degradation products by TLC chromatography
M. Starek et al.
JOURNAL OF ANALYTICAL CHEMISTRY (2009)
Glomerular filtration rate after tramadol, parecoxib and pindolol following anaesthesia and analgesia in comparison with morphine in dogs
Kavitha Kongara et al.
VETERINARY ANAESTHESIA AND ANALGESIA (2009)
Clinical effect of parecoxib in induced synovitis in horses
R. Pozzobon et al.
ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA (2008)
High-performance liquid chromatographic determination of parecoxib in human plasma and pharmaceutical formulations
S. M. T. Shaikh et al.
ANALYTICAL LETTERS (2007)
Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection
VVP Kumar et al.
BIOMEDICAL CHROMATOGRAPHY (2006)
A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and vaidecoxib in human plasma
U Werner et al.
BIOMEDICAL CHROMATOGRAPHY (2005)
HPLC determination and pharmacokinetic study of valdecoxib in human plasma
RT Sane et al.
CHROMATOGRAPHIA (2005)
Quantitation of Valdecoxib in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection using liquid-liquid extraction
NVS Ramakrishna et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Pharmacokinetics and metabolism of a COX-2 inhibitor, valdecoxib, in mice
JY Zhang et al.
DRUG METABOLISM AND DISPOSITION (2003)
N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl] sulfonyl]propanamide, sodium salt, parecoxib sodium:: A potent and selective inhibitor of COX-2 for parenteral administration
JJ Talley et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
